EA201991489A1 - Наночастицы для применения для лечения нейронального нарушения - Google Patents
Наночастицы для применения для лечения нейронального нарушенияInfo
- Publication number
- EA201991489A1 EA201991489A1 EA201991489A EA201991489A EA201991489A1 EA 201991489 A1 EA201991489 A1 EA 201991489A1 EA 201991489 A EA201991489 A EA 201991489A EA 201991489 A EA201991489 A EA 201991489A EA 201991489 A1 EA201991489 A1 EA 201991489A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- nanoparticles
- nanoparticle
- aggregate
- relates
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
- A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Organic Chemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Developmental Disabilities (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Social Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Molecular Biology (AREA)
- Manufacturing & Machinery (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Настоящее изобретение относится к области медицины, в частности к лечению неврологических расстройств. Более конкретно, настоящее изобретение относится к наночастице или агрегату наночастиц для применения в предупреждении или лечении неврологического заболевания или по меньшей мере одного его симптома у индивидуума, когда наночастицу или агрегат наночастиц подвергают воздействию электрического поля, где материал наночастицы или агрегата наночастиц выбран из проводникового материала, полупроводникового материала, изолирующего материала с диэлектрической постоянной ε, равной 200 или выше, и изолирующего материала с диэлектрической постоянной ε, равной 100 или ниже. Кроме того, оно относится к композициям и наборам, содержащим такие наночастицы и/или агрегаты наночастиц, а также к их применениям.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16306750 | 2016-12-21 | ||
| PCT/EP2017/083533 WO2018114945A1 (en) | 2016-12-21 | 2017-12-19 | Nanoparticles for use for treating a neuronal disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201991489A1 true EA201991489A1 (ru) | 2019-12-30 |
Family
ID=57850860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201991489A EA201991489A1 (ru) | 2016-12-21 | 2017-12-19 | Наночастицы для применения для лечения нейронального нарушения |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11278723B2 (ru) |
| EP (1) | EP3558373A1 (ru) |
| JP (2) | JP2020503306A (ru) |
| KR (2) | KR20230145512A (ru) |
| CN (2) | CN115590955A (ru) |
| AU (1) | AU2017384425B2 (ru) |
| BR (1) | BR112019012984A2 (ru) |
| CA (1) | CA3047649A1 (ru) |
| EA (1) | EA201991489A1 (ru) |
| IL (1) | IL267408B2 (ru) |
| MX (1) | MX2019007614A (ru) |
| NZ (1) | NZ755484A (ru) |
| WO (1) | WO2018114945A1 (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018055966A1 (ja) * | 2016-09-21 | 2018-03-29 | 富士フイルム株式会社 | 組成物、形成体、積層体、遠赤外線透過フィルタ、固体撮像素子、赤外線カメラおよび赤外線センサ |
| KR20190107027A (ko) | 2016-12-21 | 2019-09-18 | 나노비오?스 | 뉴런의 전기적 분극을 조절하는데 사용하기 위한 코팅 나노입자 |
| WO2018114945A1 (en) | 2016-12-21 | 2018-06-28 | Nanobiotix | Nanoparticles for use for treating a neuronal disorder |
| CN110382003A (zh) | 2016-12-21 | 2019-10-25 | 纳米生物技术公司 | 用于提高脑性能或用于治疗应激的纳米粒子 |
| CN111886004A (zh) * | 2017-12-19 | 2020-11-03 | 纳米生物技术公司 | 用于治疗神经元障碍的纳米粒子 |
| WO2019121813A1 (en) * | 2017-12-19 | 2019-06-27 | Nanobiotix | Nanoparticles for use in enhancing brain performances or in treating stress |
| CA3084780A1 (en) * | 2020-06-24 | 2021-12-24 | Rodney HERRING | Use of low iron oxide iron-doped titanium dioxide nanoparticles in the treatment of tumors and other diseases |
| JP2024515260A (ja) * | 2021-04-08 | 2024-04-08 | ノボキュア ゲーエムベーハー | 交流電場を用いて神経変性障害を処置する方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040254419A1 (en) * | 2003-04-08 | 2004-12-16 | Xingwu Wang | Therapeutic assembly |
| WO2006122222A2 (en) * | 2005-05-11 | 2006-11-16 | Georgia Tech Research Corporation | Shape tunable plasmonic nanoparticles |
| KR100620615B1 (ko) * | 2005-05-23 | 2006-09-06 | 한국생명공학연구원 | 가시광선 영역의 색을 갖는 금속 나노입자 혼합물이 코팅된 다색 콜로이드 입자 및 그 제조방법 |
| US20150182756A1 (en) * | 2005-08-05 | 2015-07-02 | Gholam A. Peyman | Methods to regulate polarization and enhance function of cells |
| US10596387B2 (en) * | 2007-04-08 | 2020-03-24 | Immunolight, Llc. | Tumor imaging with X-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties |
| US9358292B2 (en) * | 2007-04-08 | 2016-06-07 | Immunolight, Llc | Methods and systems for treating cell proliferation disorders |
| WO2009105662A1 (en) | 2008-02-21 | 2009-08-27 | Immunolight, Llc. | Methods and systems for treating cell proliferation disorders using plasmonics enhanced photospectral therapy (pepst) and exciton-plasmon enhanced phototherapy (epep) |
| US11235062B2 (en) | 2009-03-06 | 2022-02-01 | Metaqor Llc | Dynamic bio-nanoparticle elements |
| IT1394977B1 (it) * | 2009-04-14 | 2012-08-07 | Fond Istituto Italiano Di Tecnologia | Stimolazione elettrica cellulare mediata da nanotubi piezoelettrici |
| WO2011101039A1 (en) * | 2010-02-22 | 2011-08-25 | Universite Pierre Et Marie Curie (Paris 6) | Apparatus for the treatment of brain affections and method implementing thereof |
| CA2795289A1 (en) * | 2010-04-08 | 2011-10-13 | Sanford-Burnham Medical Research Institute | Methods and compositions for enhanced delivery of compounds |
| GB201006841D0 (en) * | 2010-04-26 | 2010-06-09 | Thomsen Lars | Method, device and system for targetted cell lysis |
| US20120263793A1 (en) * | 2011-04-14 | 2012-10-18 | Franco Vitaliano | Bio-nano-plasmonic elements and platforms |
| US10335519B2 (en) * | 2011-04-20 | 2019-07-02 | Trustees Of Tufts College | Dynamic silk coatings for implantable devices |
| EP2729175B1 (en) * | 2011-07-08 | 2021-12-01 | Duke University | System for light stimulation within a medium |
| MX362089B (es) * | 2011-12-16 | 2019-01-07 | Nanobiotix | Nanopartículas que comprenden materiales metálicos y óxido de hafnio, preparación y usos de los mismos. |
| US9272158B2 (en) | 2012-05-22 | 2016-03-01 | The Florida International University Board Of Trustees | Method for non-invasive brain stimulation |
| US9242087B2 (en) * | 2012-06-01 | 2016-01-26 | The Regents Of The University Of Michigan | Nanocomposites for neural prosthetics devices |
| PL2948179T3 (pl) * | 2013-01-25 | 2019-10-31 | Nanobiotix | Kompozycje zawierające nanocząstki tlenku hafnu(iv) lub tlenku renu(iv) w połączeniu z promieniowaniem jonizującym do leczenia nowotworu |
| WO2014202723A1 (en) | 2013-06-20 | 2014-12-24 | Nanobiotix | Compositions and methods for use in medical diagnosis |
| KR102491851B1 (ko) * | 2015-07-02 | 2023-01-26 | 삼성전자주식회사 | 마이크로 구조체를 포함하는 플렉서블 바이모달 센서 |
| KR20190107027A (ko) | 2016-12-21 | 2019-09-18 | 나노비오?스 | 뉴런의 전기적 분극을 조절하는데 사용하기 위한 코팅 나노입자 |
| WO2018114945A1 (en) | 2016-12-21 | 2018-06-28 | Nanobiotix | Nanoparticles for use for treating a neuronal disorder |
| CN110382003A (zh) | 2016-12-21 | 2019-10-25 | 纳米生物技术公司 | 用于提高脑性能或用于治疗应激的纳米粒子 |
-
2017
- 2017-12-19 WO PCT/EP2017/083533 patent/WO2018114945A1/en unknown
- 2017-12-19 EP EP17826215.0A patent/EP3558373A1/en active Pending
- 2017-12-19 AU AU2017384425A patent/AU2017384425B2/en active Active
- 2017-12-19 CA CA3047649A patent/CA3047649A1/en active Pending
- 2017-12-19 EA EA201991489A patent/EA201991489A1/ru unknown
- 2017-12-19 MX MX2019007614A patent/MX2019007614A/es unknown
- 2017-12-19 KR KR1020237033561A patent/KR20230145512A/ko active IP Right Grant
- 2017-12-19 CN CN202211141734.2A patent/CN115590955A/zh active Pending
- 2017-12-19 KR KR1020197020868A patent/KR102692689B1/ko active IP Right Grant
- 2017-12-19 BR BR112019012984A patent/BR112019012984A2/pt unknown
- 2017-12-19 CN CN201780085427.8A patent/CN110382004A/zh active Pending
- 2017-12-19 US US16/472,214 patent/US11278723B2/en active Active
- 2017-12-19 JP JP2019533316A patent/JP2020503306A/ja active Pending
- 2017-12-19 NZ NZ755484A patent/NZ755484A/en unknown
-
2019
- 2019-06-16 IL IL267408A patent/IL267408B2/en unknown
-
2022
- 2022-03-18 US US17/697,976 patent/US11717684B2/en active Active
-
2023
- 2023-03-14 JP JP2023039403A patent/JP2023075268A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3047649A1 (en) | 2018-06-28 |
| KR102692689B1 (ko) | 2024-08-06 |
| JP2020503306A (ja) | 2020-01-30 |
| IL267408B1 (en) | 2023-01-01 |
| US20220212008A1 (en) | 2022-07-07 |
| KR20230145512A (ko) | 2023-10-17 |
| MX2019007614A (es) | 2019-09-04 |
| US11278723B2 (en) | 2022-03-22 |
| KR20190105592A (ko) | 2019-09-17 |
| IL267408B2 (en) | 2023-05-01 |
| US11717684B2 (en) | 2023-08-08 |
| IL267408A (en) | 2019-08-29 |
| AU2017384425A1 (en) | 2019-08-01 |
| AU2017384425B2 (en) | 2023-08-31 |
| BR112019012984A2 (pt) | 2019-12-03 |
| WO2018114945A1 (en) | 2018-06-28 |
| CN110382004A (zh) | 2019-10-25 |
| CN115590955A (zh) | 2023-01-13 |
| NZ755484A (en) | 2023-06-30 |
| JP2023075268A (ja) | 2023-05-30 |
| EP3558373A1 (en) | 2019-10-30 |
| US20190351231A1 (en) | 2019-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201991489A1 (ru) | Наночастицы для применения для лечения нейронального нарушения | |
| EA201991521A1 (ru) | Наночастицы для применения для улучшения деятельности мозга или для лечения стресса | |
| CY1124828T1 (el) | Αλλοστερικοι διαμορφωτες των νικοτινικων υποδοχεων ακετυλχολινης | |
| EA201890767A1 (ru) | C4-модифицированные производные олеаноловой кислоты для ингибирования il-17 и других применений | |
| EA201891565A1 (ru) | Соединения и композиции для лечения состояний, ассоциированных с активностью sting | |
| EA201991375A1 (ru) | Бицикло[1.1.1]пентановые ингибиторы киназы, содержащей домен с двумя лейциновыми "застежками-молниями" (dlk), для лечения заболевания | |
| WO2017062835A3 (en) | Compositions and methods for treating duchenne muscular dystrophy and related disorders | |
| ZA202004344B (en) | Nanoparticles for use for treating a neuronal disorder | |
| NZ775767A (en) | Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders | |
| EA201391032A1 (ru) | Новые гетероциклические производные и их применение в лечении неврологических расстройств | |
| EA201990360A1 (ru) | Аналоги амилина | |
| CY1119615T1 (el) | Διπλα εκλεκτικοι αναστολεις ρι3 δελτα και γαμμα κινασης | |
| WO2019075456A3 (en) | Methods and substances for prevention and treatment of neurodegenerative diseases | |
| MX2015014944A (es) | Derivados de 3-(2-aminopiridin-4-il)-5-(3-hidroxipropinil)-1h-pirr olo[2,3-c]piridina como inhibidores de la nik para el tratamiento del cancer. | |
| EA201400969A1 (ru) | Новые терапевтические подходы для лечения болезни паркинсона | |
| EA201990450A1 (ru) | Ингибиторы киназы, содержащей домен с двумя лейциновыми "застежками-молниями" (dlk), для лечения заболевания | |
| BR112019004241A2 (pt) | composto, composição farmacêutica, uso de um composto, e, métodos de tratamento de uma doença autoimune ou inflamatória ou câncer e de artrite reumatoide | |
| PH12020551300A1 (en) | 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof | |
| ZA202004343B (en) | Nanoparticles for use in enhancing brain performances or in treating stress | |
| EA202090014A1 (ru) | Гетероароматические соединения в качестве ингибиторов ванина | |
| MA38369A1 (fr) | Peptides et compositions pour le traitement d'une lesion de l'articulation | |
| BR112019001407A2 (pt) | compostos e composições e usos dos mesmos | |
| CR20210499A (es) | Compuestos y composiciones como moduladores de la señalización de tlr | |
| MX2019001421A (es) | Composiciones de reelina para el tratamiento de trastornos neurologicos. | |
| CY1124821T1 (el) | Ιγμεσινη για χρηση στη θεραπεια της νοσου του αλτσχαιμερ |